Delivery Order SPE2DB20D3111-SPE2DB24FA9DH

Award Date 9/12/24
Potential Completion Date 9/13/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The $3,866.80 firm fixed-price contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical for delivering a wide range of medical commodities to support military treatment programs...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,529.38 firm fixed-price contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a completion date of February 3, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The contract has a firm fixed price of $4,647.12 and a period of performance ending on September 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract is not set-aside for any specific business type. This delivery order is part of a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $4,647.12 firm-fixed-price contract provides for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of September 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications, medical supplies, and...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has a ceiling value of $10,891.64 and is a firm fixed-price agreement. Amerisourcebergen, a major pharmaceutical distributor, is delivering these medical supplies to support military treatment programs and facilities through a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $4,647.12 to provide MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. This delivery order was issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The $6,421.18 firm-fixed price contract has an ultimate completion date of August 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract is a Firm Fixed Price (FFP) agreement with a ceiling value of $15,163.97 and an ultimate completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $14,855.34, is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies. It has an ultimate completion date of July 8, 2022. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,940.56, is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract is a Firm Fixed Price Delivery Order that does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...
  • SPE2DB20D3111
    Indefinite Delivery Contract
  • SPE2DB20D3111-SPE2DB24FA9DH
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has a firm fixed price of $10,704.62 and a completion date of September 13, 2024. AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is the prime contractor. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure a wide range of medical commodities, including prescription drugs and medical supplies, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/12/24, 9:45 AM